Published in World J Gastroenterol on March 14, 2008
Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut (2002) 4.01
Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreas. Hepatology (2006) 2.83
Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch (2005) 2.76
Mucin-hypersecreting bile duct tumor characterized by a striking homology with an intraductal papillary mucinous tumor (IPMT) of the pancreas. Endoscopy (2000) 2.13
Intraductal papillary neoplasia of the liver associated with hepatolithiasis. Hepatology (2001) 2.07
Clinicopathologic review of 58 patients with biliary papillomatosis. Cancer (2004) 2.05
Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients. Cancer (2002) 1.82
Pathologic features of mucin-producing bile duct tumors: two histopathologic categories as counterparts of pancreatic intraductal papillary-mucinous neoplasms. Am J Surg Pathol (2004) 1.59
Clinicopathologic features of the intraductal growth type of peripheral cholangiocarcinoma. Hepatology (2000) 1.43
Biliary papillary neoplasm of the liver. Histol Histopathol (2002) 1.38
Cholangiographic spectrum of intraductal papillary mucinous neoplasm of the bile ducts. Ann Surg (2006) 1.36
Intraductal papillary mucinous tumor of the bile ducts. Radiographics (2004) 1.34
Clonality and field cancerization in intraductal papillary-mucinous tumors of the pancreas. Cancer (2001) 1.29
Precancerous lesions of intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg (2000) 1.27
An intraductal papillary component is associated with prolonged survival after hepatic resection for intrahepatic cholangiocarcinoma. Br J Surg (2004) 1.15
Aberrant expression of CDX2 is closely related to the intestinal metaplasia and MUC2 expression in intraductal papillary neoplasm of the liver in hepatolithiasis. Lab Invest (2004) 1.09
Intraductal mucinous tumors occurring simultaneously in the liver and pancreas. J Gastroenterol (2002) 1.05
Characterization of intrahepatic cholangiocarcinoma of the intraductal growth-type and its precursor lesions. Hepatology (2005) 1.05
Hepatic intraductal oncocytic papillary carcinoma. Cancer (2002) 0.98
Increasing expression of gastrointestinal phenotypes and p53 along with histologic progression of intraductal papillary neoplasia of the liver. Hum Pathol (2002) 0.98
Imaging diagnosis of bile duct cystadenocarcinoma. Cancer (1988) 0.96
Intrahepatic cholangiocarcinoma with multicystic, mucinous appearance and oncocytic change. Pathol Int (2005) 0.77
Prophylactic impact of endoscopic treatment for esophageal varices in liver resection: a prospective study. J Gastroenterol (2013) 2.08
Efficacy and safety of entecavir in lamivudine-refractory patients with chronic hepatitis B: randomized controlled trial in Japanese patients. J Gastroenterol Hepatol (2008) 1.78
Persistent infection of hepatitis E virus transmitted by blood transfusion in a patient with T-cell lymphoma. Hepatol Res (2007) 1.45
Advantages of jejunal pouch in Roux-en-Y reconstruction. Hepatogastroenterology (2012) 1.42
Influence of occult hepatitis B virus coinfection on the incidence of fibrosis and hepatocellular carcinoma in chronic hepatitis C. Intervirology (2009) 1.06
Transcription of dbpA, a Y box binding protein, is positively regulated by E2F1: implications in hepatocarcinogenesis. Biochem Biophys Res Commun (2004) 1.06
Hepatitis e virus infection in fulminant hepatitis patients and an apparently healthy population in Bangladesh. Am J Trop Med Hyg (2002) 0.99
Preduodenal portal vein, intestinal malrotation, polysplenia, and interruption of the inferior vena cava: a review of anatomical anomalies associated with gastric cancer. Surg Radiol Anat (2011) 0.99
Serum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in C-viral chronic liver diseases. Cancer (2002) 0.98
Efficacy and safety of entecavir in nucleoside-naive, chronic hepatitis B patients: phase II clinical study in Japan. J Gastroenterol Hepatol (2009) 0.98
HCV NS5A resistance-associated variants in a group of real-world Japanese patients chronically infected with HCV genotype 1b. Hepatol Int (2015) 0.97
Decreased production of interleukin-12 and type 2 immune responses are marked in cachectic patients with colorectal and gastric cancer. J Clin Gastroenterol (2002) 0.96
Long-term outcome of laparoscopic cystogastrostomy performed using a posterior approach with a stapling device. Dig Surg (2009) 0.96
Zinc supplementation improves the outcome of chronic hepatitis C and liver cirrhosis. J Clin Biochem Nutr (2009) 0.96
SEN virus infection does not affect the progression of non-A to -E liver disease. J Med Virol (2002) 0.93
Association of interleukin-28B genotype and hepatocellular carcinoma recurrence in patients with chronic hepatitis C. Clin Cancer Res (2013) 0.92
Long-term survival after resection of mass-forming type intrahepatic cholangiocarcinoma directly infiltrating the transverse colon and sequential brain metastasis: Report of a case. Surg Today (2011) 0.90
Long-term outcome of laparoscopic deroofing for symptomatic nonparasitic liver cysts. Hepatogastroenterology (2009) 0.88
Development of pyrrole-imidazole polyamide for specific regulation of human aurora kinase-A and -B gene expression. Chem Biol (2008) 0.88
Efficacy and resistance of entecavir following 3 years of treatment of Japanese patients with lamivudine-refractory chronic hepatitis B. Hepatol Int (2010) 0.87
The Expression of Murine Double Minute 2 (MDM2) on Helicobacter pylori-Infected Intestinal Metaplasia and Gastric Cancer. J Clin Biochem Nutr (2009) 0.86
Analysis of background factors and evaluation of a population at high risk of hepatocellular carcinoma. Intervirology (2003) 0.86
Small intestinal perforation due to metastasis of breast carcinoma: report of a case. Surg Today (2011) 0.86
Jejunal scarf-covering method in pancreaticojejunostomy after total gastrectomy. Case Rep Gastroenterol (2012) 0.85
A novel technique of mediastinoscopy-assisted esophagectomy with a flexible laparoscope and endoscopic overtube. Surg Laparosc Endosc Percutan Tech (2010) 0.85
Spontaneous Regression of Polyposis following Abdominal Colectomy and Helicobacter pylori Eradication for Cronkhite-Canada Syndrome. Case Rep Gastroenterol (2013) 0.84
Diffuse Peritonitis due to Perforated Gastric Ectopic Pancreas. Case Rep Gastroenterol (2012) 0.84
Laparoscopic excision for an enlarged ciliated hepatic foregut cyst as a minimally invasive procedure. J Laparoendosc Adv Surg Tech A (2009) 0.84
Pneumatosis cystoides intestinalis after fluorouracil chemotherapy for rectal cancer. World J Gastroenterol (2008) 0.83
Preoperatively undetected solitary bile duct hamartoma (von Meyenburg complex) associated with esophageal carcinoma. Int J Clin Oncol (2008) 0.82
Influence of neutrophil elastase inhibitor on the postoperative course in patients with esophageal cancer after transthoracic esophagectomy. Hepatogastroenterology (2011) 0.82
Protection of major vessels and pancreaticogastrostomy using the falciform ligament and greater omentum for preventing pancreatic fistula in soft pancreatic texture after pancreaticoduodenectomy. Hepatogastroenterology (2011) 0.82
Immunomodulatory effects of low dose cis-Diaminedichloroplatinum (cisplatin) combined with UFT and PSK in patients with advanced colorectal cancer. Cancer Invest (2002) 0.82
Pericardiocentesis with cisplatin for malignant pericardial effusion and tamponade. World J Gastroenterol (2010) 0.82
Impaction of a lithotripsy basket during endoscopic lithotomy of a common bile duct stone. World J Gastroenterol (2010) 0.82
Preventing delayed gastric emptying in pancreaticogastrostomy by a modified subtotal-stomach-preserving pancreaticoduodenectomy: Oida modification. Hepatogastroenterology (2011) 0.82
Modified Devine exclusion with vertical stomach reconstruction for gastric outlet obstruction: a novel technique. J Gastrointest Surg (2009) 0.82
An adult patient with acute hepatitis type B which was protracted and complicated by polyarteritis nodosa: a case report. Hepatol Res (2002) 0.82
Antecolic and retrocolic route on delayed gastric emptying after MSSPPD. Hepatogastroenterology (2012) 0.81
Zinc supplementation therapy improves the outcome of patients with chronic hepatitis C. J Clin Biochem Nutr (2012) 0.81
Pancreaticogastrostomy in patients with considerably dilated pancreatic ducts. Hepatogastroenterology (2012) 0.81
HCV core protein promotes heparin binding EGF-like growth factor expression and activates Akt. Hepatol Res (2011) 0.81
Palliative enteric bypass for malignant gastric outflow obstruction after pancreaticoduodenectomy in early recurrent pancreatic cancer. Hepatogastroenterology (2011) 0.81
Low frequency of anti-SLA/LP autoantibody in Japanese adult patients with autoimmune liver diseases: analysis with recombinant antigen assay. J Autoimmun (2003) 0.81
Anastomotic stricture of Billroth-I gastroduodenostomy using a hemi-double stapling technique. Hepatogastroenterology (2009) 0.80
Histopathology of type C liver disease for determining hepatocellular carcinoma risk factors. World J Gastroenterol (2013) 0.80
Detection of serum and intrahepatic hepatocyte growth factor during DEN-induced carcinogenesis in the rat. Hepatol Res (2002) 0.80
Detection of telomerase activity, telomerase RNA component, and telomerase reverse transcriptase in human hepatocellular carcinoma. Hepatol Res (2004) 0.80
Reconstruction following pancreaticoduodenectomy for patients who have previously undergone partial gastrectomy. Hepatogastroenterology (2010) 0.80
Fixation of the round ligament to the peritoneum and wrapping of the cut surface of the liver for prevention of early delayed gastric emptying after hepatic lateral segmentectomy. Langenbecks Arch Surg (2008) 0.79
Hand-assisted laparoscopic hepatectomy for primary clear cell hepatocellular carcinoma of the liver. Case Rep Gastroenterol (2012) 0.79
Killian-jamieson diverticula presenting synchronously with thyroid adenoma. Case Rep Gastroenterol (2013) 0.79
A long-surviving patient with unresectable advanced gastric cancer responding to S-1 after receiving improved gastrojejunostomy. Int J Clin Oncol (2004) 0.79
Effects of lansoprazole on the expression of VEGF and cellular proliferation in a rat model of acetic acid-induced gastric ulcer. J Gastroenterol (2010) 0.78
Isoniazid-induced acute liver failure during preventive therapy for latent tuberculosis infection. Intern Med (2015) 0.78
Use of a highly sensitive latex reagent with amino acid spacer for determination of C-reactive protein concentration in a variety of liver diseases. J Biosci Bioeng (2012) 0.78
Association of single nucleotide polymorphisms of the interleukin-10 promoter gene and susceptibility to primary biliary cirrhosis: immunogenetic differences in Italian and Japanese patients. Autoimmunity (2002) 0.78
Efficacy of antibiotic combination therapy in patients with active ulcerative colitis, including refractory or steroid-dependent cases. J Gastroenterol Hepatol (2010) 0.78
Horizontal vs. vertical incision on the anterior gastric wall in pancreaticogastrostomy. Hepatogastroenterology (2012) 0.78
Vertical stomach reconstruction with pancreaticogastrostomy after modified subtotal-stomach-preserving pancreaticoduodenectomy for preventing delayed gastric emptying. Hepatogastroenterology (2009) 0.77
A new surgical technique of transduodenal pancreatic juice drainage prevents pancreatic fistula following distal pancreatectomy. Hepatogastroenterology (2011) 0.77
PBC-AIH overlap syndrome with concomitant ITP and Hashimoto's disease with positivity for anti-centromere antibody. J Gastroenterol (2004) 0.77